Pharmacy Benefit Managers’ Attack on Physician Dispensing and Impact on Patient Care; Case Study of CVS Caremark’s Efforts to Restrict Access to Cancer Care: This whitepaper was supported in part by UroGPO and is a direct exploitation of the efforts of CVS Caremark to prevent physicians from providing appropriate and economical care to their patients. (

Defining Deliverables of PCa Fusion-Targeted Biopsy: In this article, published in Renal and Urology News, the authors describe proposed metrics to quantify and compare deliverables of targeted biopsy technologies. (source: